Top Markets
Coin of the day
Definium Therapeutics, Inc. Definium Therapeutics, Inc.

Definium Therapeutics, Inc.

DFTX
株式のランク #3212
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm... Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
株価
$44.42
最終同期: 2026-08-25
時価総額
$5.90B
変化(1日)
2.66%
変化(1年)
344.66%
US
取引 Definium Therapeutics, Inc. (DFTX)

カテゴリー

Definium Therapeutics, Inc.(DFTX)の株価履歴
終値の最高値: $44.49 (2026-08-01)

終値の最安値: $4.81 (2016-11-01)
Definium Therapeutics, Inc. の株価履歴(2016 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 65.08%
2025 74.98%
2024 107.98%
2023 34.70%
2022 -89.90%
2021 -40.72%
2020 7,946.66%
2019 -31.09%
2018 -81.58%
2017 -37.50%
2016 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$122.63 -12.26%
AU
$772.27 7.33%
CH